Advertisement
Research Article Free access | 10.1172/JCI114761
Department of Human Genetics, Yale University School of Medicine, New Haven, Connecticut 06510.
Find articles by Yokota, I. in: JCI | PubMed | Google Scholar
Department of Human Genetics, Yale University School of Medicine, New Haven, Connecticut 06510.
Find articles by Indo, Y. in: JCI | PubMed | Google Scholar
Department of Human Genetics, Yale University School of Medicine, New Haven, Connecticut 06510.
Find articles by Coates, P. in: JCI | PubMed | Google Scholar
Department of Human Genetics, Yale University School of Medicine, New Haven, Connecticut 06510.
Find articles by Tanaka, K. in: JCI | PubMed | Google Scholar
Published September 1, 1990 - More info
We sequenced polymerase chain reaction (PCR)-amplified variant medium chain acyl-CoA dehydrogenase (MCAD) cDNAs in cultured fibroblasts from three MCAD-deficient patients. In all three patients, an A to G transition was identified at position 985 of the coding region. Since no appropriate restriction sites for detecting this point mutation were found, we devised a PCR method that amplifies an 87-bp fragment from position 955. In the 5' primer encompassing positions 955 to 984, A-981 was artificially substituted with C. With the presence of C-981 and G-985, an Nco I restriction site is introduced in the mutant copies. When cDNA or genomic DNA from fibroblasts of nine MCAD-deficient patients were tested with this method, the copies from all of them completely cleaved into two shorter fragments by Nco I, indicating their homozygosity for the A----G-985 transition. In contrast, the copies from all eight controls remained intact. Thus, this A----G-985 transition is the single prevalent mutation causing MCAD deficiency, a highly unusual feature for any genetic disorder. The PCR/Nco I digestion method is suitable for the diagnosis of MCAD deficiency.
Images.
Click on an image below to see the page. View PDF of the complete article